National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Availability of the Draft Expert Panel Report on Bisphenol A and Request for Public Comment on the Draft Report; Announcement of the Bisphenol A Expert Panel Meeting, 74534-74536 [E6-21040]

Download as PDF 74534 Federal Register / Vol. 71, No. 238 / Tuesday, December 12, 2006 / Notices obtained after that date by contacting NICEATM (see FOR FURTHER INFORMATION CONTACT above). Attendance and Registration This public meeting will take place February 6, 2007, at the NIH Campus, Natcher Conference Center, Bethesda, MD (a map of the NIH campus and other visitor information are available at https://www.nih.gov/about/visitor/ index.htm). The meeting begins at 8:30 a.m. and will conclude at approximately 5 p.m. Persons needing special assistance, such as sign language interpretation or other reasonable accommodation in order to attend, should contact 919–541–2475 (voice), 919–541–4644 TTY (text telephone), through the Federal TTY Relay System at 800–877–8339, or by e-mail to niehsoeeo@niehs.nih.gov. Requests should be made at least seven business days in advance of the event. jlentini on PROD1PC65 with NOTICES Availability of the BRD and Draft ICCVAM Recommendations NICEATM prepared a BRD on five in vitro pyrogenicity test methods that describes the current validation status of the in vitro test methods and contains all of the data and analyses supporting this validation status. The draft BRDs, draft ICCVAM test method recommendations, draft test method protocols, and draft test method performance standards are available from the ICCVAM/NICETAM Web site (https://iccvam.niehs.nih.gov) or by contacting NICEATM (see FOR FURTHER INFORMATION CONTACT above). Request for Comments NICEATM invites the submission of written comments on the BRDs, draft ICCVAM test method recommendations, draft test method protocols, and draft test method performance standards. When submitting written comments, it is important to refer to this Federal Register notice and include appropriate contact information (name, affiliation, mailing address, phone, fax, e-mail, and sponsoring organization, if applicable). Written comments should be sent by mail, fax, or e-mail to Dr. William Stokes, Director of NICEATM, at the address listed above, not later than January 26, 2007. All comments received will be placed on the ICCVAM/ NICEATM Web site (https:// iccvam.niehs.nih.gov), sent to the panel and ICCVAM agency representatives, and made available at the meeting. This meeting is open to the public and time will be provided for the presentation of public oral comments at designated times during the peer review. Members of the public who VerDate Aug<31>2005 18:00 Dec 11, 2006 Jkt 211001 wish to present oral statements at the meeting (one speaker per organization) should contact NICEATM (see FOR FURTHER INFORMATION CONTACT above) no later than January 26, 2007. Speakers will be assigned on a consecutive basis and up to seven minutes will be allotted per speaker. Persons registering to make comments are asked to provide NICEATM a written copy of their statement by January 26, 2007, so that copies can be distributed to the panel prior to the meeting or if this is not possible to bring 40 copies to the meeting. Written statements can supplement and expand the oral presentation. Each speaker is asked to provide contact information (name, affiliation, mailing address, phone, fax, e-mail, and sponsoring organization, if applicable) when registering to make oral comments. Summary minutes and the panel’s final report will be available following the meeting on the ICCVAM/NICEATM Web site (https://iccvam.niehs.nih.gov). ICCVAM will consider the panel’s conclusions and recommendations and any public comments received in finalizing their test method recommendations and performance standards for these methods. Background Information on ICCVAM and NICEATM ICCVAM is an interagency committee composed of representatives from 15 Federal regulatory and research agencies that use or generate toxicological information. ICCVAM conducts technical evaluations of new, revised, and alternative methods with regulatory applicability and promotes the scientific validation and regulatory acceptance of toxicological test methods that more accurately assess the safety and hazards of chemicals and products and that refine, reduce, and replace animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l–3, available at https://iccvam.niehs.nih.gov/about/ PL106545.htm) establishes ICCVAM as a permanent interagency committee of the NIEHS under the NICEATM. NICEATM administers ICCVAM and provides scientific and operational support for ICCVAM-related activities. NICEATM and ICCVAM work collaboratively to evaluate new and improved test methods applicable to the needs of federal agencies. Additional information about ICCVAM and NICEATM can be found at the following Web site: https://iccvam.niehs.nih.gov. PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Dated: November 27, 2006. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E6–21038 Filed 12–11–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Center for the Evaluation of Risks to Human Reproduction (CERHR); Availability of the Draft Expert Panel Report on Bisphenol A and Request for Public Comment on the Draft Report; Announcement of the Bisphenol A Expert Panel Meeting National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH). ACTION: Announcement of a meeting and request public comment. AGENCY: SUMMARY: The CERHR announces the availability of the draft expert panel report for bisphenol A on December 15, 2006, from the CERHR Web site (https://cerhr.niehs.nih.gov) or in printed text from CERHR (see FOR FURTHER INFORMATION CONTACT below). The CERHR invites the submission of public comments on sections 1–4 of the draft expert panel report (see SUPPLEMENTARY INFORMATION below). The expert panel will meet on March 5–7, 2007, at the Radisson Hotel Old Town in Alexandria, Virginia to review and revise the draft expert panel report and reach conclusions regarding whether exposure to bisphenol A is a hazard to human development or reproduction. The expert panel will also identify data gaps and research needs. CERHR expert panel meetings are open to the public with time scheduled for oral public comment. Attendance is limited only by the available meeting room space. Following the expert panel meeting and completion of the expert panel report, the CERHR will post the final report on its Web site and solicit public comment on it through a Federal Register notice. DATES: The expert panel meeting for bisphenol A will be held on March 5– 7, 2007. Sections 1–4 of the draft expert panel report will be available for public comment on December 15, 2006. Written public comments on the draft report must be received by February 2, 2007. Time is set-aside at the expert panel meeting on March 5, 2007 for oral public comments. Individuals wishing to make oral public comments are asked to contact Dr. Michael D. Shelby, E:\FR\FM\12DEN1.SGM 12DEN1 Federal Register / Vol. 71, No. 238 / Tuesday, December 12, 2006 / Notices CERHR Director, by February 26, 2007, and if possible, send a copy of the statement or talking points at that time. Persons needing special assistance, such as sign language interpretation or other reasonable accommodation in order to attend, should contact 919–541–2475 (voice), 919–541–4644 TTY (text telephone), through the Federal TTY Relay System at 800–877–8339, or by e-mail to niehsoeeo@niehs.nih.gov. Requests should be made at least seven business days in advance of the event. ADDRESSES: The expert panel meeting on bisphenol A will be held at the Radisson Hotel Old Town 901 N. Fairfax Street Alexandria, Virginia 22314–1501 (telephone: 703–683–6000, facsimile: 703–683–7597). Comments on the draft expert panel report should be sent to Dr. Michael D. Shelby, CERHR Director, NIEHS, P.O. Box 12233, MD EC–32, Research Triangle Park, NC 27709 (mail), (919) 316–4511 (fax), or shelby@niehs.nih.gov (e-mail). Courier address: CERHR, 79 T.W. Alexander Drive, Building 4401, Room 103, Research Triangle Park, NC 27709. FOR FURTHER INFORMATION CONTACT: Dr. Michael D. Shelby, CERHR Director, 919–541–3455, shelby@niehs.nih.gov. SUPPLEMENTARY INFORMATION: jlentini on PROD1PC65 with NOTICES Background Bisphenol A (CAS RN: 80–5–07) is a high production volume chemical used in the production of epoxy resins, polyester resins, polysulfone resins, polyacrylate resins, polycarbonate plastics, and flame retardants. Polycarbonate plastics are used in food and drink packaging; resins are used as lacquers to coat metal products such as food cans, bottle tops, and water supply pipes. Some polymers used in dental sealants and tooth coatings contain bisphenol A. Exposure to the general population can occur through direct contact to bisphenol A or by exposure to food or drink that has been in contact with a material containing bisphenol A. CERHR selected this chemical for evaluation because of (1) high production volume, (2) widespread human exposure, (3) evidence of reproductive toxicity in laboratory animal studies, and (4) public concern. At the meeting, the expert panel will review and revise the draft expert panel report and reach conclusions regarding whether exposure to bisphenol A is a hazard to human reproduction or development. Each draft expert panel report has the following sections: 1.0 Chemistry, Use, and Human Exposure. 2.0 General Toxicological and Biological Effects. 3.0 Developmental Toxicity Data. 4.0 Reproductive Toxicity Data. 5.0 Summary, Conclusions, and Critical Data Needs (to be prepared at expert panel meeting). Request for Comments The CERHR invites written public comments on sections 1–4 of the draft expert panel report on bisphenol A. Any comments received will be posted on the CERHR website prior to the meeting and distributed to the expert panel and CERHR staff for their consideration in revising the draft report and/or preparing for the expert panel meeting. Persons submitting written comments are asked to include their name and contact information (affiliation, mailing address, telephone and facsimile numbers, e-mail, and sponsoring organization, if any) and send them to Dr. Shelby (see ADDRESSES above) for receipt by February 2, 2007. Time is set-aside on March 5, 2007, for the presentation of oral public comments at the expert panel meeting. Seven minutes will be available for each speaker (one speaker per organization). When registering to comment orally, please provide your name, affiliation, mailing address, telephone and facsimile numbers, email and sponsoring organization (if any). If possible, send a copy of the statement or talking points to Dr. Shelby by February 2. This statement will be provided to the expert panel to assist Robert E. Chapin, PhD (Chair) ................................................................ Jane Adams, PhD .................................................................................... Kim Boekelheide, MD, PhD ...................................................................... Michael A. Gallo, PhD .............................................................................. Leon Earl Gray, Jr, PhD ........................................................................... Simon William Hayward, PhD .................................................................. Peter S.J. Lees, PhD ................................................................................ Barry S. McIntyre, PhD ............................................................................ Michael John McPhaul, MD ..................................................................... Kenneth Portier, PhD ............................................................................... Teresa Schnorr, PhD ................................................................................ Sherry G. Selevan, PhD ........................................................................... John G. Vandenbergh, PhD ..................................................................... Kendall B. Wallace, PhD .......................................................................... VerDate Aug<31>2005 18:00 Dec 11, 2006 Jkt 211001 PO 00000 Frm 00051 Fmt 4703 74535 them in identifying issues for discussion and will be noted in the meeting record. Registration for presentation of oral comments will also be available at the meeting on March 5, 2007, from 7:30– 8:30 a.m. Persons registering at the meeting are asked to bring 20 copies of their statement or talking points for distribution to the expert panel and for the record. Preliminary Agenda The meeting begins each day at 8:30 a.m. On March 5 and 6, it is anticipated that a lunch break will occur from noon–1 p.m. and the meeting will adjourn at 5–6 p.m. The meeting is expected to adjourn by noon on March 7; however, adjournment may occur earlier or later depending upon the time needed by the expert panel to complete its work. Anticipated agenda topics for each day are listed below. March 5, 2007 • Opening remarks. • Oral public comments (7 minutes per speaker; one representative per group). • Review of sections 1–4 of the draft expert panel report on bisphenol A. • Discussion of Section 5.0 Summary, Conclusions, and Critical Data Needs. March 6, 2007 • Discussion of Section 5.0 Summary, Conclusions, and Critical Data Needs. • Preparation of draft summaries and conclusion statements. March 7, 2007 • Presentation, discussion of, and agreement on summaries, conclusions, and data needs. • Closing comments. Expert Panel Roster The CERHR expert panel is composed of independent scientists selected for their scientific expertise in reproductive and/or developmental toxicology and other areas of science relevant for these evaluations. Pfizer Inc., Groton, CT. University of Massachusetts, Boston, MA. Brown University, Providence, RI. University of Medicine & Dentistry NJ, Piscataway, NJ. U.S. Environmental Protection Agency, Research Triangle Park, NC. Vanderbilt University Medical Center, Nashville, TN. The Johns Hopkins University, Baltimore, MD. Schering-Plough Research Institute, Summit, NJ. The University of Texas, Dallas, Texas. American Cancer Society, Atlanta, GA. Centers for Disease Control, National Institute for Occupational Safety & Health, Cincinnati, OH. Retired, U.S. Public Health Service, Silver Spring, MD. North Carolina State University, Raleigh, NC. University of Minnesota, Duluth, MN. Sfmt 4703 E:\FR\FM\12DEN1.SGM 12DEN1 74536 Federal Register / Vol. 71, No. 238 / Tuesday, December 12, 2006 / Notices Susan R. Woskie, PhD ............................................................................. Background Information on the CERHR The NTP established CERHR in June 1998 [Federal Register, December 14, 1998 (Volume 63, Number 239, page 68782)]. CERHR is a publicly accessible resource for information about adverse reproductive and/or developmental health effects associated with exposure to environmental and/or occupational exposures. Expert panels conduct scientific evaluations of agents selected by the CERHR in public forums. CERHR invites the nomination of agents for review or scientists for its expert registry. Information about CERHR and the nomination process can be obtained from its homepage (https:// cerhr.niehs.nih.gov) or by contacting Dr. Shelby (see FOR FURTHER INFORMATION CONTACT above). CERHR selects chemicals for evaluation based upon several factors including production volume, potential for human exposure from use and occurrence in the environment, extent of public concern, and extent of data from reproductive and developmental toxicity studies. CERHR follows a formal, multi-step process for review and evaluation of selected chemicals. The formal evaluation process was published in the Federal Register on July 16, 2001 (Volume 66, Number 136, pages 37047– 37048) and is available on the CERHR Web site under ‘‘About CERHR’’ or in printed copy from CERHR. Dated: November 27, 2006. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E6–21040 Filed 12–11–06; 8:45 am] BILLING CODE 4140–01–P University of Massachusetts Lowell, Lowell, MA. DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, Department of Health and Human Services. ACTION: Notice. AGENCY: home setting. The instrument will be pilot tested with staff in 40 nursing homes. The data collected will be analyzed to determine the psychometric properties of the survey’s items and dimensions and provide information for the revision and shortening of the final survey based on an assessment of its reliability and construct validity. The final survey will be made publicly available to enable nursing homes to assess their resident safety culture. Methods of Collection SUMMARY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) allow the proposed information collection project: ‘‘Pilot Study of Proposed Nursing Home Survey on Resident Safety’’. In accordance with the Paperwork Reduction Act of 1995, Public Law 104– 13 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection. DATES: Comments on this notice must be received by February 12, 2007. ADDRESSES: Written comments should be submitted to: Doris Lefkowitz, Reports Clearance Officer, AHRQ, 540 Gaither Road, Room #5036, Rockville, MD 20850. Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from AHRQ’s Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ, Reports Clearance Officer, (301) 427–1477. SUPPLEMENTARY INFORMATION: A purposive sample of 40 nursing homes will be recruited and selected. These nursing homes will represent a distrubition of bed size, nature of ownership (non-profit/for-profit), urbanity (urban/rural), and geographic region of the United States. Recruited nursing homes will be allocated to each category in numbers roughly proportionate to the national distribution of homes in each category. All employees, contractors and agency staff in all job classes in nursing homes with up to 200 employees will be asked to respond to the survey. In nursing homes with more than 200 employees, a random sample of 200 employees will be selected. Since not all nursing homes staff have access to or are familiar with e-mail or the internet, paper surveys will be administered. Standard non-response follow-up techniques such as reminder postcards and distrubiton of a second survey will be used. Individuals and organizations contacted will be assured of the confidentiality of their replies under Section 924(c) of the Healthcare Research and Quality Act of 1999. Proposed Project Estimated Annual Respondent Burden ‘‘Pilot Study of Proposed Nursing Home Survey on Resident Safety’’ This activity is an expansion and refinement of AHRQ’s Hospital Survey on Patient Safety Culture (HSOPSC) which was developed and released to the public for use in November 2004. This proposed new tool is based on the HSOPSC but also contains new and revised items as well as dimensions that more accurately apply to the nursing The survey will be distributed to approximately 5,500 nursing home employees, with a target response rate of 70%, or 3,850 returned surveys. Respondents should take approximately 15 minutes to complete the survey. Therefore, we estimate that the respondent burden for completing the survey will be 963 hours (3,850 completes multiplied by 0.25 hours per completed survey). jlentini on PROD1PC65 with NOTICES Type of Respondent Number of Respondents Number of Responses per Respondent Estimated Time per Respondent (hours) Estimated Total Respondent Burden Hours Nursing home staff member ............................................................................ 3,850 1 0.25 963 VerDate Aug<31>2005 18:00 Dec 11, 2006 Jkt 211001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\12DEN1.SGM 12DEN1

Agencies

[Federal Register Volume 71, Number 238 (Tuesday, December 12, 2006)]
[Notices]
[Pages 74534-74536]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21040]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Toxicology Program (NTP); Center for the Evaluation of 
Risks to Human Reproduction (CERHR); Availability of the Draft Expert 
Panel Report on Bisphenol A and Request for Public Comment on the Draft 
Report; Announcement of the Bisphenol A Expert Panel Meeting

AGENCY: National Institute of Environmental Health Sciences (NIEHS); 
National Institutes of Health (NIH).

ACTION: Announcement of a meeting and request public comment.

-----------------------------------------------------------------------

SUMMARY: The CERHR announces the availability of the draft expert panel 
report for bisphenol A on December 15, 2006, from the CERHR Web site 
(https://cerhr.niehs.nih.gov) or in printed text from CERHR (see FOR 
FURTHER INFORMATION CONTACT below). The CERHR invites the submission of 
public comments on sections 1-4 of the draft expert panel report (see 
SUPPLEMENTARY INFORMATION below). The expert panel will meet on March 
5-7, 2007, at the Radisson Hotel Old Town in Alexandria, Virginia to 
review and revise the draft expert panel report and reach conclusions 
regarding whether exposure to bisphenol A is a hazard to human 
development or reproduction. The expert panel will also identify data 
gaps and research needs. CERHR expert panel meetings are open to the 
public with time scheduled for oral public comment. Attendance is 
limited only by the available meeting room space. Following the expert 
panel meeting and completion of the expert panel report, the CERHR will 
post the final report on its Web site and solicit public comment on it 
through a Federal Register notice.

DATES: The expert panel meeting for bisphenol A will be held on March 
5-7, 2007. Sections 1-4 of the draft expert panel report will be 
available for public comment on December 15, 2006. Written public 
comments on the draft report must be received by February 2, 2007. Time 
is set-aside at the expert panel meeting on March 5, 2007 for oral 
public comments. Individuals wishing to make oral public comments are 
asked to contact Dr. Michael D. Shelby,

[[Page 74535]]

CERHR Director, by February 26, 2007, and if possible, send a copy of 
the statement or talking points at that time. Persons needing special 
assistance, such as sign language interpretation or other reasonable 
accommodation in order to attend, should contact 919-541-2475 (voice), 
919-541-4644 TTY (text telephone), through the Federal TTY Relay System 
at 800-877-8339, or by e-mail to niehsoeeo@niehs.nih.gov. Requests 
should be made at least seven business days in advance of the event.

ADDRESSES: The expert panel meeting on bisphenol A will be held at the 
Radisson Hotel Old Town 901 N. Fairfax Street Alexandria, Virginia 
22314-1501 (telephone: 703-683-6000, facsimile: 703-683-7597). Comments 
on the draft expert panel report should be sent to Dr. Michael D. 
Shelby, CERHR Director, NIEHS, P.O. Box 12233, MD EC-32, Research 
Triangle Park, NC 27709 (mail), (919) 316-4511 (fax), or 
shelby@niehs.nih.gov (e-mail). Courier address: CERHR, 79 T.W. 
Alexander Drive, Building 4401, Room 103, Research Triangle Park, NC 
27709.

FOR FURTHER INFORMATION CONTACT: Dr. Michael D. Shelby, CERHR Director, 
919-541-3455, shelby@niehs.nih.gov.

SUPPLEMENTARY INFORMATION:

Background

    Bisphenol A (CAS RN: 80-5-07) is a high production volume chemical 
used in the production of epoxy resins, polyester resins, polysulfone 
resins, polyacrylate resins, polycarbonate plastics, and flame 
retardants. Polycarbonate plastics are used in food and drink 
packaging; resins are used as lacquers to coat metal products such as 
food cans, bottle tops, and water supply pipes. Some polymers used in 
dental sealants and tooth coatings contain bisphenol A. Exposure to the 
general population can occur through direct contact to bisphenol A or 
by exposure to food or drink that has been in contact with a material 
containing bisphenol A. CERHR selected this chemical for evaluation 
because of (1) high production volume, (2) widespread human exposure, 
(3) evidence of reproductive toxicity in laboratory animal studies, and 
(4) public concern.
    At the meeting, the expert panel will review and revise the draft 
expert panel report and reach conclusions regarding whether exposure to 
bisphenol A is a hazard to human reproduction or development. Each 
draft expert panel report has the following sections:

1.0 Chemistry, Use, and Human Exposure.
2.0 General Toxicological and Biological Effects.
3.0 Developmental Toxicity Data.
4.0 Reproductive Toxicity Data.
5.0 Summary, Conclusions, and Critical Data Needs (to be prepared at 
expert panel meeting).

Request for Comments

    The CERHR invites written public comments on sections 1-4 of the 
draft expert panel report on bisphenol A. Any comments received will be 
posted on the CERHR website prior to the meeting and distributed to the 
expert panel and CERHR staff for their consideration in revising the 
draft report and/or preparing for the expert panel meeting. Persons 
submitting written comments are asked to include their name and contact 
information (affiliation, mailing address, telephone and facsimile 
numbers, e-mail, and sponsoring organization, if any) and send them to 
Dr. Shelby (see ADDRESSES above) for receipt by February 2, 2007.
    Time is set-aside on March 5, 2007, for the presentation of oral 
public comments at the expert panel meeting. Seven minutes will be 
available for each speaker (one speaker per organization). When 
registering to comment orally, please provide your name, affiliation, 
mailing address, telephone and facsimile numbers, email and sponsoring 
organization (if any). If possible, send a copy of the statement or 
talking points to Dr. Shelby by February 2. This statement will be 
provided to the expert panel to assist them in identifying issues for 
discussion and will be noted in the meeting record. Registration for 
presentation of oral comments will also be available at the meeting on 
March 5, 2007, from 7:30-8:30 a.m. Persons registering at the meeting 
are asked to bring 20 copies of their statement or talking points for 
distribution to the expert panel and for the record.

Preliminary Agenda

    The meeting begins each day at 8:30 a.m. On March 5 and 6, it is 
anticipated that a lunch break will occur from noon-1 p.m. and the 
meeting will adjourn at 5-6 p.m. The meeting is expected to adjourn by 
noon on March 7; however, adjournment may occur earlier or later 
depending upon the time needed by the expert panel to complete its 
work. Anticipated agenda topics for each day are listed below.

March 5, 2007

     Opening remarks.
     Oral public comments (7 minutes per speaker; one 
representative per group).
     Review of sections 1-4 of the draft expert panel report on 
bisphenol A.
     Discussion of Section 5.0 Summary, Conclusions, and 
Critical Data Needs.

March 6, 2007

     Discussion of Section 5.0 Summary, Conclusions, and 
Critical Data Needs.
     Preparation of draft summaries and conclusion statements.

March 7, 2007

     Presentation, discussion of, and agreement on summaries, 
conclusions, and data needs.
     Closing comments.

Expert Panel Roster

    The CERHR expert panel is composed of independent scientists 
selected for their scientific expertise in reproductive and/or 
developmental toxicology and other areas of science relevant for these 
evaluations.

------------------------------------------------------------------------
 
------------------------------------------------------------------------
Robert E. Chapin, PhD (Chair)..........  Pfizer Inc., Groton, CT.
Jane Adams, PhD........................  University of Massachusetts,
                                          Boston, MA.
Kim Boekelheide, MD, PhD...............  Brown University, Providence,
                                          RI.
Michael A. Gallo, PhD..................  University of Medicine &
                                          Dentistry NJ, Piscataway, NJ.
Leon Earl Gray, Jr, PhD................  U.S. Environmental Protection
                                          Agency, Research Triangle
                                          Park, NC.
Simon William Hayward, PhD.............  Vanderbilt University Medical
                                          Center, Nashville, TN.
Peter S.J. Lees, PhD...................  The Johns Hopkins University,
                                          Baltimore, MD.
Barry S. McIntyre, PhD.................  Schering-Plough Research
                                          Institute, Summit, NJ.
Michael John McPhaul, MD...............  The University of Texas,
                                          Dallas, Texas.
Kenneth Portier, PhD...................  American Cancer Society,
                                          Atlanta, GA.
Teresa Schnorr, PhD....................  Centers for Disease Control,
                                          National Institute for
                                          Occupational Safety & Health,
                                          Cincinnati, OH.
Sherry G. Selevan, PhD.................  Retired, U.S. Public Health
                                          Service, Silver Spring, MD.
John G. Vandenbergh, PhD...............  North Carolina State
                                          University, Raleigh, NC.
Kendall B. Wallace, PhD................  University of Minnesota,
                                          Duluth, MN.

[[Page 74536]]

 
Susan R. Woskie, PhD...................  University of Massachusetts
                                          Lowell, Lowell, MA.
------------------------------------------------------------------------

Background Information on the CERHR

    The NTP established CERHR in June 1998 [Federal Register, December 
14, 1998 (Volume 63, Number 239, page 68782)]. CERHR is a publicly 
accessible resource for information about adverse reproductive and/or 
developmental health effects associated with exposure to environmental 
and/or occupational exposures. Expert panels conduct scientific 
evaluations of agents selected by the CERHR in public forums.
    CERHR invites the nomination of agents for review or scientists for 
its expert registry. Information about CERHR and the nomination process 
can be obtained from its homepage (https://cerhr.niehs.nih.gov) or by 
contacting Dr. Shelby (see FOR FURTHER INFORMATION CONTACT above). 
CERHR selects chemicals for evaluation based upon several factors 
including production volume, potential for human exposure from use and 
occurrence in the environment, extent of public concern, and extent of 
data from reproductive and developmental toxicity studies.
    CERHR follows a formal, multi-step process for review and 
evaluation of selected chemicals. The formal evaluation process was 
published in the Federal Register on July 16, 2001 (Volume 66, Number 
136, pages 37047-37048) and is available on the CERHR Web site under 
``About CERHR'' or in printed copy from CERHR.

    Dated: November 27, 2006.
Samuel H. Wilson,
Deputy Director, National Institute of Environmental Health Sciences 
and National Toxicology Program.
[FR Doc. E6-21040 Filed 12-11-06; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.